Transforming growth factor-β-activated kinase 1 (TAK1), a key component of the TLR4 MyD88-dependent signalling pathway, has also shown promise as a potentially valuable target for protecting against CIN. Here, TLR4 is linked to cervical squamous intraepithelial neoplasia.